Home › HIV › District of Columbia
HIV clinical trials in District of Columbia
9 studies for HIV are looking for participants at sites in District of Columbia.
Cities in District of Columbia
A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
- GSK Investigational Site, Washington D.C.
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Sep 28, 2026 · NCT07650916El Camino HIV Prevention and Care Study
- La Clínica del Pueblo, Washington D.C.
Recruiting
Ages 18 and older · Men · Updated Sep 22, 2026 · NCT07834853A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
- Whitman-Walker Institute ( Site 1538), Washington D.C.
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT07266831Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study
- George Washington University, Washington D.C.
Recruiting
Ages 45 to 80 · All sexes · Updated Aug 19, 2026 · NCT04949464Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
- George Washington University, Washington D.C.
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jun 1, 2026 · NCT05663502The DC Cohort Longitudinal HIV Status Neutral Study
- Kaiser Permanente Mid-Atlantic States, Washington D.C.
- Unity Health Care, Washington D.C.
- Georgetown University, Washington D.C.
- and 11 more
RecruitingObservational studyHealthy volunteers welcome
All ages · All sexes · Updated Feb 2, 2026 · NCT01206920Peer Behavioral Activation Utilization to Improve Substance Use and HIV Outcomes in People Receiving Long Acting Injectable-PrEP/ART (PUSH)
- HIPS (Harm reduction drop-in center), Washington D.C.
RecruitingHealthy volunteers welcome
Ages 18 to 88 · All sexes · Updated Oct 31, 2025 · NCT06501781Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics
- GSK Investigational Site, Washington D.C.
RecruitingPhase 1/2
Ages 6 to 12 · All sexes · Updated Sep 19, 2024 · NCT05674656Comparing Mobile Health Strategies to Improve Pre-exposure Prophylaxis Use (PrEP) for HIV Prevention
- Whitman-Walker Health, Washington D.C.
RecruitingHealthy volunteers welcome
Ages 15 and older · All sexes · Updated Sep 28, 2022 · NCT04855773From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.